Key result
Plasma platelet-activating factor acetylhydrolase fluctuates during critical illness with uncertain clinical implications.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
PAF-AH dynamics do not inform management; leaves open its potential as a biomarker or target for prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Guy A. Zimmerman (2005) studied this question. Plasma platelet-activating factor acetylhydrolase functions as a dynamic variable during critical illness, though the clinical implications of its fluctuation remain uncertain.
Synapse has enriched 10 related papers. Consider them for comparative context: